No Data
No Data
Why These 4 ASX 200 Shares Just Got Downgraded by Top Brokers
Four S&P/ASX 200 Index (ASX: XJO) shares just had their medium-term outlook slashed by leading brokers.
Jarden Adjusts Sonic Healthcare Price Target to AU$26.19 From AU$28.88, Keeps at Neutral
Sonic Healthcare (ASX:SHL) has an average rating of hold and price targets ranging from AU$22.50 to AU$33.00, according to analysts polled by CapitalIQ. Price (AUD): $24.57, Change: $-0.45, Percent Ch
Sonic's FY 2025 Profit Guidance May Be Conservative -- Market Talk
0020 GMT - Morgans thinks Sonic Healthcare's disappointing earnings guidance for FY 2025 could end up being too low. Sonic expects FY 2025 Ebitda of A$1.70 billion-A$1.75 billion when currency swings
Sonic's Pathology Margins Likely Lower for Longer -- Market Talk
2334 GMT - Sonic Healthcare's margins in its pathology business are likely to stay lower for longer, according to Citi. Sonic's management signaled in February that pathology margins could recover to
Sonic May Struggle to Maintain High Profit Growth Amid Inflationary Pressures -- Market Talk
2315 GMT - Sonic Healthcare's profit guidance is a reminder that clinical lab companies are largely price takers and high levels of profit growth may be difficult in the medium term if inflationary pr
Sonic Healthcare Price Target Cut 19% to A$25.00/Share by Citi
Sonic Healthcare Price Target Cut 19% to A$25.00/Share by Citi
No Data